Disclosure Regarding Forward-Looking Statements
The SpyGlass Pharma, Inc. website (including any materials and other information made available on this website), articles and publications authored by SpyGlass Pharma representatives, and other statements by SpyGlass Pharma (including its officers, directors, employees and authorized representatives) may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements that are not purely historical are forward-looking statements, including, but not limited to, statements regarding the potential of SpyGlass Pharma’s BIM-IOL System to become the new standard of care for cataracts patients with glaucoma, through the integration of three known components into one integrated solution, and market size estimates for the BIM-IOL System. These forward-looking statements are based upon current expectations and involve assumptions that may never materialize or may prove to be incorrect. These forward-looking statements are neither promises nor guarantees and are subject to a variety of risks and uncertainties, including, but not limited to, SpyGlass Pharma’s ability to obtain FDA approval for the BIM-IOL System; the ability of the BIM-IOL System to achieve market acceptance by surgeons, patients and others in the medical community; third party competition; and other risks and uncertainties set forth in the Risk Factors section of SpyGlass Pharma’s most recent reports on Form 10-K, 10-Q and 8-K filed with the U.S. Securities and Exchange Commission (SEC), and in similar disclosures set forth in the other documents that SpyGlass Pharma may file from time to time with the SEC. These forward-looking statements are made as of the date of the respective website posting, material or publication, and the creators assume no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. The views in these forward-looking statements should not be relied on as representing the creator’s views as of any date subsequent to the date of the respective material.